Literature DB >> 11886377

Class III receptor tyrosine kinases: role in leukaemogenesis.

John T Reilly1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11886377     DOI： 10.1046/j.0007-1048.2001.03294.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  28 in total

1.  Screening of the c-kit gene missense mutation in invasive ductal carcinoma of breast among north Indian population.

Authors:  Syed Rizwan Hussain; Sunil G Babu; Syed Tasleem Raza; Pradyumn Singh; Faisal Ahmed; Hena Naqvi; Farzana Mahdi
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

Review 2.  Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature.

Authors:  Jun Zhou; Peter Papenhausen; Haipeng Shao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

Authors:  Zhijian Qian; Anthony A Fernald; Lucy A Godley; Richard A Larson; Michelle M Le Beau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

4.  KIT proto-oncogene exon 8 deletions at codon 419 are highly frequent in acute myeloid leukaemia with inv(16) in Indian population.

Authors:  Syed Rizwan Hussain; Hena Naqvi; Farzana Mahdi; Cherry Bansal; Sunil G Babu
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

5.  Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.

Authors:  Zhifu Xiang; Frederike Kreisel; Jennifer Cain; AnnaLynn Colson; Michael H Tomasson
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

6.  AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

Authors:  Yue-Ying Wang; Guang-Biao Zhou; Tong Yin; Bing Chen; Jing-Yi Shi; Wen-Xue Liang; Xiao-Long Jin; Jian-Hua You; Guang Yang; Zhi-Xiang Shen; Jue Chen; Shu-Min Xiong; Guo-Qiang Chen; Feng Xu; Yi-Wei Liu; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-13       Impact factor: 11.205

7.  Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature.

Authors:  Sheng-Lan Gong; Meng-Qiao Guo; Gu-Sheng Tang; Chun-Ling Zhang; Hui-Ying Qiu; Xiao-Xia Hu; Jian-Min Yang
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

8.  A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.

Authors:  J Sun; M Zhu; W Shen; C Wang; J Dai; L Xu; G Jin; Z Hu; H Ma; H Shen
Journal:  Pharmacogenomics J       Date:  2016-03-08       Impact factor: 3.550

Review 9.  Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib.

Authors:  Gunhild Mechtersheimer; Gerlinde Egerer; Manfred Hensel; Ralf J Rieker; Martin Libicher; Thomas Lehnert; Roland Penzel
Journal:  Virchows Arch       Date:  2004-01-20       Impact factor: 4.064

10.  Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations.

Authors:  Tadayuki Akagi; Lee-Yung Shih; Motohiro Kato; Norihiko Kawamata; Go Yamamoto; Masashi Sanada; Ryoko Okamoto; Carl W Miller; Der-Cherng Liang; Seishi Ogawa; H Phillip Koeffler
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.